WomenNow-TV's video: GIOSTAR announces FDA approval for COVID 19 GIOSTAR Stem Cell Treatment Know about the company

San Diego, California-based Global Institute of Stem Cell Therapy and Research, a leader in stem cell research, has announced that they have received an approval for a COVID-19 clinical trial, led by their Indian American medical director Dr. Prabhat Soni. GIOSTAR will conduct the trial using stem cells to treat COVID-19 patients under the approval of the United States Food and Drug Administration "expanded access for compassionate use" program". Stem cells make a tremendous promise to treat degenerative diseases. Giostar is a leading stem cell research company. It was born in India with the vision to provide adult stem cell therapy to people suffering from degenerative or genetic diseases around the world. Headquartered in San Diego, California, GIOSTAR has the ability to treat multiple Immunological and Blood related diseases by safe extraction, preparation (per disease), and the re introduction of stem cells into the human body to achieve the maximum possible results for each and every patient. Ena Sarkar talks to scientist Anand Shrivastava and his team on Stem Cell Therapy and how it will soon revolutionize health care. Host : Ena Sarkar Executive Producer : Kalpana Malviya Producer : Sameer Targe (Zee TV) Producer : Ena Sarkar (WomenNow TV) Production Manager : Sancharee Ghosh DOP : John Zukowski Camera Person : Kirk Schroeder Editor : Robert Smith